iAvoxel is a Moroccan medical-AI group by SOYO BUSINESS — not one platform, but two independent products. Each one lives in its own space below.
When a patient has a cardiac emergency in a rural area, reaching a specialist takes on average four hours — not because hospitals don't exist, but because they don't share records, bed availability or transfers. Zero digital traceability.
Early screening is rare, unaffordable and concentrated in capital cities. Families wait years for a first evaluation — time when intervention would change lifetime outcomes.
iAvoxel is a medical-AI group, not a single platform. Under the iAvoxel brand, we build and operate two standalone clinical products: IACárdio for hospital coordination (with the IA Cardio 4G BP Holter as a companion device), and iAutisme for clinical autism screening. Each product has its own platform, its own team, its own pilot pipeline, its own investor story. No bundling, no cross-dependency — they share only sovereign Moroccan hosting and the iAvoxel brand.
A regional inter-hospital coordination platform — 25 clinical modules, ready, tested, configurable in days.
IACárdio is the regional inter-hospital coordination platform for Africa — 25 clinical modules covering the full patient journey from rural health centre to teaching hospital. Pre-configured for 29 hospitals in Morocco's Oriental region, configurable for any region or country in 30 days. Quadrilingual (French · English · Arabic · ⵜⴰⵎⴰⵣⵉⵖⵜ Tamazight), sovereign, and built around three clinical pillars: inter-service télé-expertise, regional shared appointment calendar, and a patient portal for remote appointment requests and prescription renewal.
The connected companion device that feeds IACárdio in real time.
A 4G-connected ambulatory blood-pressure Holter that records 72 hours of measurements and transmits them live to the physician and to the IACárdio platform. Seven internationally recognised validations are delivered with every device, and delivery is 60 days from order.
A full clinical platform for autism care — from early screening to lifelong longitudinal follow-up.
iAutisme is not just a screening tool, it is a complete clinical platform that covers every step of autism care: early screening, clinical assessment, individual education planning, behavior intervention, therapy session tracking, wearables monitoring, telehealth and longitudinal follow-up across the child's lifetime. Six dashboards for six roles (family, educator, specialist, association, ministry, admin) keep everyone in sync on the same sovereign infrastructure.
Each product has its own maturity timeline. They do not share a roadmap. Read your column, make your call.
Most global medtech assumes bandwidth, insurance, identity and distribution. iAvoxel assumes none of these and delivers anyway.
Hosted in Morocco. Health data stays on national infrastructure.
National patient ID via NFC — one tap, no smartphone required.
Interoperable with hospital information systems and public health records.
Arabic, French and English — clinicians, patients and families.
Live IACárdio demo, iAutisme walkthrough, and pilot discussions with ministries, hospitals and investors. Book a private slot in advance.
Hospitals, ministries, investors, distributors — if you care about scaling medical infrastructure in Africa, we want to hear from you.